ClinicalTrials.Veeva

Menu
S

San Jose Clinical Trials | San Jose, CA

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Lorundrostat
Maridebart Cafraglutide
Rilzabrutinib
SAB-142

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 6 total trials

A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related Disease (RILIEF)

This is a Phase 3, parallel group, 2-arm, randomized, double blind, placebo-controlled, 52-week treatment study to assess the efficacy and safety of...

Enrolling
Immunoglobulin G4 Related Disease
Drug: Rilzabrutinib
Drug: Placebo

The main purpose of this study is to assess the dose-response relationship of maridebart cafraglutide on glucose control compared with placebo.

Active, not recruiting
Type 2 Diabetes Mellitus (T2DM)
Drug: Maridebart Cafraglutide
Drug: Placebo

Phase 2 study to evaluate the safety, tolerability, PK, immunogenicity, and pharmacodynamics of solriktug with adult participants with asthma.

Active, not recruiting
Asthma
Biological: NSI-8226
Biological: Placebo

This study is to evaluate the long-term safety, efficacy and tolerability of lorundrostat (an aldosterone synthase inhibitor) in subjects with hypert...

Active, not recruiting
Hypertension
Drug: lorundrostat
Drug: Placebo

This is a Phase 2b, investigator- and participant-blinded, placebo-controlled, parallel-arm study to evaluate the efficacy, safety and tolerability o...

Enrolling
Type 1 Diabetes
Drug: Low Dose SAB-142
Other: Placebo

Trial sponsors

M
Amgen logo
S
Sanofi logo
U

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems